FindTrial
Sign In

The use of methylene blue dye in the diagnosis of dysplasia in Barrett's Oesophagus Surveillance

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN15254497
Enrollment
Unknown
Registered
2003-09-12
Start date
2003-01-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive System: Dysplasia Digestive System Dysplasia

Interventions

1. Methylene blue directed biopsies 2. Random biopsies

Sponsors

Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Barrett's oesophagus patients with recent diagnosis of dysplasia

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

MeasureTime frame
The frequency of dysplasia between methylene blue directed biopsies and random biopsies.—

Secondary

MeasureTime frame
Not provided at time of registration—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026